SkinBioTherapeutics (LSE:SBTX) Short-Term Capital Lease Obligation : £0.04 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Short-Term Capital Lease Obligation?

SkinBioTherapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.04 Mil.

SkinBioTherapeutics's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (£0.03 Mil) to Jun. 2023 (£0.03 Mil) and increased from Jun. 2023 (£0.03 Mil) to Dec. 2023 (£0.04 Mil).

SkinBioTherapeutics's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (£0.03 Mil) to Jun. 2022 (£0.03 Mil) and increased from Jun. 2022 (£0.03 Mil) to Jun. 2023 (£0.03 Mil).

SkinBioTherapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for SkinBioTherapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Short-Term Capital Lease Obligation Chart

SkinBioTherapeutics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.03

SkinBioTherapeutics Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										0.03	0.03	0.03	0.03	0.04

SkinBioTherapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

SkinBioTherapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

SkinBioTherapeutics (LSE:SBTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF

Website

https://www.skinbiotherapeutics.com

SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.